Feasibility of Comprehensive Genomic Profiling (CGP) in Real-Life Clinical Practice
Diagnostics · 19.02.2023 · 13 (4) · 782
DOI: 10.3390/diagnostics13040782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 19.02.2023. Verfasst von Lorenzo Nibid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Anatomical Pathology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21-00128 Ro…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In advanced or metastatic settings, Comprehensive Genomic Profiling (CGP) allows the evaluation of thousands of gene alterations with the goal of offering new opportunities for personalized treatment in solid tumors. This study evaluated the CGP Success Rate in a real-life cohort of 184 patients enrolled in a prospective clinical trial. CGP data were compared with the routine molecular testing strategy adopted in-house. Sample age, tumor area, and the percentage of tumor nuclei were recorded for CGP analysis. We found that 150/184 (81.5%) samples resulted in satisfying CGP reports. The CGP Success Rate was higher in samples from surgical specimens (96.7%) and in specimens that had been stored (sample age) for less than six months (89.4%). Among the inconclusive CGP reports, 7/34 (20.6%) were optimal samples, according to CGP sample requirements. Moreover, with the in-house molecular testing approach, we could obtain clinically relevant molecular data in 25/34 (73.5%) samples that had inconclusive CGP reports. In conclusion, despite the fact that CGP offers specific therapeutical options in selected patients, our data suggest that the standard molecular testing strategy should not be replaced in routine molecular profiling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Unit of Anatomical Pathology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21-00128 Roma, Italy.
- Anatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128 Roma, Italy.
- Research Unit of General Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21-00128 Roma, Italy.
- Thoracic Surgery Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128 Roma, Italy.
- Research Unit of Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21-00128 Roma, Italy.
- Medical Oncology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128 Roma, Italy.
ORCID-Profile: Lorenzo Nibid, Silvia Maria Rossi, Pierfilippo Crucitti, Giuseppe Perrone
Zitieren
APA
Nibid, L., Sabarese, G., Righi, D., Rossi, S. M., Merlini, G., Crucitti, P., Vincenzi, B., Tonini, G., & Perrone, G. (2023). Feasibility of Comprehensive Genomic Profiling (CGP) in Real-Life Clinical Practice. Diagnostics, 13(4), 782. https://doi.org/10.3390/diagnostics13040782
Vancouver
Nibid L, Sabarese G, Righi D, Rossi SM, Merlini G, Crucitti P, et al. Feasibility of Comprehensive Genomic Profiling (CGP) in Real-Life Clinical Practice. Diagnostics. 2023;13(4):782. doi:10.3390/diagnostics13040782
BibTeX
@article{Nibid2023,
author = {Nibid, Lorenzo and Sabarese, Giovanna and Righi, Daniela and Rossi, Silvia Maria and Merlini, Giorgia and Crucitti, Pierfilippo and Vincenzi, Bruno and Tonini, Giuseppe and Perrone, Giuseppe},
title = {Feasibility of Comprehensive Genomic Profiling (CGP) in Real-Life Clinical Practice},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {4},
pages = {782},
doi = {10.3390/diagnostics13040782}
}
EUVIMED